Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.69 USD | +0.71% | -0.66% | +13.37% |
Mar. 14 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
Mar. 13 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
Evolution of the average Target Price on Anika Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Anika Therapeutics, Inc.
Barrington Research | |
Stephens Inc. | |
UBS |
EPS Revisions
- Stock Market
- Equities
- ANIK Stock
- Consensus Anika Therapeutics, Inc.